By Susan Crabtree
Posted: 09/24/08 04:11 PM [ET]

After two months of Rep. Charles Rangel asking the ethics committee to investigate him, the panel Wednesday launched a formal probe into the multiple allegations piled up around the powerful New York Democrat.

The committee voted to establish an investigative subcommittee to conduct an inquiry, a ( Read more... )

alin's Ethics Scrapes May Undercut Pledge to End Old Politics

By Timothy J. Burger and Tony Hopfinger


( Read more... )

Letter Described
Situation as 'Grave,'
Called for Apology
By JIM CARLTON
September 11, 2008; Page A8
ANCHORAGE, Alaska -- An informal adviser who has counseled Gov. Sarah Palin on ethics issues urged her in July to apologize for her handling of the dismissal of the state's public safety commissioner and warned that the matter could snowball ( Read more... )

Timothy J. Burger and Tony HopfingerThu Sep 11, 12:01 AM ET

Sept. 11 (Bloomberg) -- John McCain's choice of Sarah Palin as his running mate sent a signal that he would end business as usual and cronyism in government. Her record shows the Alaska governor engaged in some of the same practices she and McCain now condemn.

Palin's office approved a ( Read more... )

Goss among former members appointed to ethics office

By Susan Crabtree

Posted: 07/24/08 02:26 PM [ET]

House Speaker Nancy Pelosi (D-Calif.) and Minority Leader John Boehner (R-Ohio) on Thursday announced joint appointments to a landmark ethics review board that for the first time will allow private citizens to review allegations against members.

Still ( Read more... )

Ethics Complaints Filed Over Obama Mortgage Rate
The conservative public-interest group Judicial Watch today filed ethics complaints alleging that Sen. Barack Obama (D-Ill.), the presumptive Democratic presidential nominee, broke the rules when he accepted a discounted deal on a 2005 mortgage loan, as first reported last week by The Post.

" ( Read more... )

FDA Puts Medical Test Subjects in Danger By Sonia Shah

May 19, 2008

Now that 80 percent of clinical trials fail to recruit sufficient numbers of test subjects on deadline, drug companies increasingly export their trials to developing countries, where sick, undertreated patients abound. It's faster, it's cheaper and it's easier to ( Read more... )